BioNTech and CureVac: mRNA is Trending as other Age Groups become COVID-19 Participants BNTX
BioNTech: What is the impact of other age groups? BioNTech ($BNTX) and pharmaceutical partner Pfizer ($PFE) started the registration study for a corona vaccine in July 2020. Initially, the COVID-19 vaccine candidate would be tested on up to 30,000 participants between the ages of 18 and 85. Meanwhile, BioNTech and Pfizer have received FDA approval…